Eduardo Bruera, Medical Doctor at MD Anderson Cancer Center, shared on LinkedIn:
“Only 1 in 4 patients receiving opioids in an ambulatory cancer pain clinic received a UDT order, suggesting a more selective rather than routine use. UDT ordering was more common among patients with a SOAPP-14 score ≥ 7 and a history of substance use disorder. Among patients who underwent UDT, approximately one-third had abnormal results.”
Title: Urine Drug Testing at an Ambulatory Pain Clinic in Patients Receiving Opioids for Cancer Pain
Authors: Jaya Amaram-Davila, Varsha Pawate, Sriram Yennurajalingam, Ali Mehdi Rizvi, Rosheni Kandaswamy, Reaundra Mccullough-Roach, Sonal Admane, Min Ji Kim, Akhila Reddy, Lei Feng, Larry Driver, Eduardo Bruera, Joseph A Arthur, Dhanalakshmi Koyyalagunta
You can also read:
Wenchang Yue: Rethinking Urine Testing for Bladder Cancer Surveillance
